{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:38:39Z","timestamp":1790638719369,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A2A1A05001873"],"award-info":[{"award-number":["2015R1A2A1A05001873"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C3002751"],"award-info":[{"award-number":["2019R1A2C3002751"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A5A1004694"],"award-info":[{"award-number":["2016R1A5A1004694"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Researchers have shown increased interest in determining what stimulates height. Currently, many children undergo precocious puberty, resulting in short stature due to premature closure of the growth plate. However, the current approach for height enhancement is limited to growth hormone treatment, which often results in side effects and clinical failure and is costly. Although recent studies have indicated the importance of paracrine signals in the growth plate for longitudinal bone growth, height-stimulating agents targeting the signaling pathways involved in growth plate maturation remain unavailable in the clinic. The Wnt\/\u03b2-catenin pathway plays a major role in the maturation of growth plate chondrocytes. In this study, by using an ex vivo tibial culture system, we identified indirubin-3\u2032-oxime (I3O) as a compound capable of enhancing longitudinal bone growth. I3O promoted chondrocyte proliferation and differentiation via activation of the Wnt\/\u03b2-catenin pathway in vitro. Intraperitoneal injection of I3O in adolescent mice increased growth plate height along with incremental chondrocyte maturation. I3O promoted tibial growth without significant adverse effects on bone thickness and articular cartilage. Therefore, I3O could be a potential therapeutic agent for increasing height in children with growth retardation.<\/jats:p>","DOI":"10.1038\/s12276-019-0306-3","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T04:46:44Z","timestamp":1568263604000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Indirubin-3\u2032-oxime stimulates chondrocyte maturation and longitudinal bone growth via activation of the Wnt\/\u03b2-catenin pathway"],"prefix":"10.1038","volume":"51","author":[{"given":"Sehee","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu-Hyeon","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Yi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Yell","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"306_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tem.2004.08.004","volume":"15","author":"O Nilsson","year":"2004","unstructured":"Nilsson, O. & Baron, J. Fundamental limits on longitudinal bone growth: growth plate senescence and epiphyseal fusion. Trends Endocrinol. Metab. 15, 370\u2013374 (2004).","journal-title":"Trends Endocrinol. Metab."},{"key":"306_CR2","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1210\/jc.2003-031457","volume":"89","author":"EW Leschek","year":"2004","unstructured":"Leschek, E. W. et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89, 3140\u20133148 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"306_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrendo.2015.165","volume":"11","author":"J Baron","year":"2015","unstructured":"Baron, J. et al. Short and tall stature: a new paradigm emerges. Nat. Rev. Endocrinol. 11, 735\u2013746 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"306_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1590\/S0004-27302011000800009","volume":"55","author":"FM Souza","year":"2011","unstructured":"Souza, F. M. & Collett-Solberg, P. F. Adverse effects of growth hormone replacement therapy in children. Arq. Bras. Endocrinol. Metabol. 55, 559\u2013565 (2011).","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"306_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature01657","volume":"423","author":"HM Kronenberg","year":"2003","unstructured":"Kronenberg, H. M. Developmental regulation of the growth plate. Nature 423, 332\u2013336 (2003).","journal-title":"Nature"},{"key":"306_CR6","doi-asserted-by":"publisher","first-page":"a008334","DOI":"10.1101\/cshperspect.a008334","volume":"5","author":"F Long","year":"2013","unstructured":"Long, F. & Ornitz, D. M. Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 5, a008334 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"306_CR7","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1359\/jbmr.2000.15.12.2431","volume":"15","author":"DA Stevens","year":"2000","unstructured":"Stevens, D. A., Hasserjian, R. P., Robson, H., Siebler, T., Shalet, S. M. & Williams, G. R. Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J. Bone Miner. Res. 15, 2431\u20132442 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"306_CR8","doi-asserted-by":"publisher","first-page":"13689","DOI":"10.1073\/pnas.94.25.13689","volume":"94","author":"E Schipani","year":"1997","unstructured":"Schipani, E. et al. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc. Natl Acad. Sci. USA 94, 13689\u201313694 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"306_CR9","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1101\/gad.1171104","volume":"18","author":"H Akiyama","year":"2004","unstructured":"Akiyama, H. et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18, 1072\u20131087 (2004).","journal-title":"Genes Dev."},{"key":"306_CR10","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/jbmr.1639","volume":"27","author":"DY Dao","year":"2012","unstructured":"Dao, D. Y. et al. Cartilage-specific beta-catenin signaling regulates chondrocyte maturation, generation of ossification centers, and perichondrial bone formation during skeletal development. J. Bone Miner. Res. 27, 1680\u20131694 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"306_CR11","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1242\/jcs.020362","volume":"121","author":"M Chen","year":"2008","unstructured":"Chen, M. et al. Inhibition of beta-catenin signaling causes defects in postnatal cartilage development. J. Cell Sci. 121, 1455\u20131465 (2008).","journal-title":"J. Cell Sci."},{"key":"306_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ygeno.2006.01.007","volume":"87","author":"D Simon-Chazottes","year":"2006","unstructured":"Simon-Chazottes, D. et al. Mutations in the gene encoding the low-density lipoprotein receptor LRP4 cause abnormal limb development in the mouse. Genomics 87, 673\u2013677 (2006).","journal-title":"Genomics"},{"key":"306_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10561-014-9449-6","volume":"16","author":"J Zhou","year":"2015","unstructured":"Zhou, J. et al. Inactivation of glycogen synthase kinase-3beta up-regulates beta-catenin and promotes chondrogenesis. Cell Tissue Bank 16, 135\u2013142 (2015).","journal-title":"Cell Tissue Bank"},{"key":"306_CR14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1210\/en.2010-1412","volume":"152","author":"JR Gillespie","year":"2011","unstructured":"Gillespie, J. R. et al. Deletion of glycogen synthase kinase-3beta in cartilage results in up-regulation of glycogen synthase kinase-3alpha protein expression. Endocrinology 152, 1755\u20131766 (2011).","journal-title":"Endocrinology"},{"key":"306_CR15","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1172\/JCI35243E1","volume":"118","author":"Y Kawasaki","year":"2008","unstructured":"Kawasaki, Y. et al. Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J. Clin. Invest. 118, 2506\u20132515 (2008).","journal-title":"J. Clin. Invest."},{"key":"306_CR16","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ijo.2013.209","volume":"38","author":"OM Choi","year":"2014","unstructured":"Choi, O. M. et al. The small molecule indirubin-3\u2032-oxime activates Wnt\/beta-catenin signaling and inhibits adipocyte differentiation and obesity. Int. J. Obes. 38, 1044\u20131052 (2014).","journal-title":"Int. J. Obes."},{"key":"306_CR17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1210\/er.2002-0033","volume":"24","author":"BC van der Eerden","year":"2003","unstructured":"van der Eerden, B. C., Karperien, M. & Wit, J. M. Systemic and local regulation of the growth plate. Endocr. Rev. 24, 782\u2013801 (2003).","journal-title":"Endocr. Rev."},{"key":"306_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jpeds.2013.04.002","volume":"163","author":"S Sisley","year":"2013","unstructured":"Sisley, S., Trujillo, M. V., Khoury, J. & Backeljauw, P. Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. J. Pediatr. 163, 1045\u20131051 (2013).","journal-title":"J. Pediatr."},{"key":"306_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/dbio.1997.8536","volume":"185","author":"JA Rudnicki","year":"1997","unstructured":"Rudnicki, J. A. & Brown, A. M. Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev. Biol. 185, 104\u2013118 (1997).","journal-title":"Dev. Biol."},{"key":"306_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/(SICI)1097-4652(199909)180:3<314::AID-JCP2>3.0.CO;2-Y","volume":"180","author":"NS Stott","year":"1999","unstructured":"Stott, N. S., Jiang, T. X. & Chuong, C. M. Successive formative stages of precartilaginous mesenchymal condensations in vitro: modulation of cell adhesion by Wnt-7A and BMP-2. J. Cell Physiol. 180, 314\u2013324 (1999).","journal-title":"J. Cell Physiol."},{"key":"306_CR21","doi-asserted-by":"publisher","first-page":"19185","DOI":"10.1074\/jbc.M414275200","volume":"280","author":"Y Tamamura","year":"2005","unstructured":"Tamamura, Y. et al. Developmental regulation of Wnt\/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 280, 19185\u201319195 (2005).","journal-title":"J. Biol. Chem."},{"key":"306_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bone.2013.03.019","volume":"55","author":"S Golovchenko","year":"2013","unstructured":"Golovchenko, S. et al. Deletion of beta catenin in hypertrophic growth plate chondrocytes impairs trabecular bone formation. Bone 55, 102\u2013112 (2013).","journal-title":"Bone"},{"key":"306_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00432-004-0579-2","volume":"130","author":"G Eisenbrand","year":"2004","unstructured":"Eisenbrand, G., Hippe, F., Jakobs, S. & Muehlbeyer, S. Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J. Cancer Res. Clin. Oncol. 130, 627\u2013635 (2004).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"306_CR24","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/jbmr.2147","volume":"29","author":"M Zahoor","year":"2014","unstructured":"Zahoor, M., Cha, P. H., Min, D. S. & Choi, K. Y. Indirubin-3\u2032-oxime reverses bone loss in ovariectomized and hindlimb-unloaded mice via activation of the Wnt\/beta-catenin signaling. J. Bone Miner. Res. 29, 1196\u20131205 (2014).","journal-title":"J. Bone Miner. Res."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0306-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:56Z","timestamp":1684617056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0306-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["306"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0306-3","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.-Y.C. is the CEO of CK Biotechnology Inc., headquartered in Seoul, Korea, which has a license to develop and use the compounds disclosed in the publication. The remaining authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}